Growth Opportunities in the Medical Aesthetics Market To 2021Science & Nature StoresUpdated on Aug 8, 2016 View more like this | Visit SAN FRANCISCO, CA | Contact Market Reports Center |
Latest cutting-edge report Global Medical Aesthetics Industry: Injectables, Energy-Based Devices, Cosmeceuticals, Cosmetic Surgery, Facial Aesthetics, Implants, Cosmetic Tourism. Market Analysis & Forecast to 2021 (Published August 2016) is a most comprehensive analysis on this vertically growing market. This detailed report provides strategic business development information and is supported by 180 tables & figures over 335 pages.
Currently, invasive aesthetic procedures generated revenues of $27,843.5 million in 2015. New Report indicate that by 2021, invasive aesthetic procedures will grow at a CAGR of 4.3%, to reach $27,843.5 million. Non-invasive procedures generated approximately $16,738 million in 2015 and will grow at a CAGR of 4.5% over the coming five years. They are expected to generate revenues of $16,738.0 million in 2021. Cosmetic surgery products generated $7,824.0 million in 2015 and have the potential to reach $13,934.0 million in 2021.
The global market for the medical aesthetics industry is presented by the following categories:
• By Geography (North America, Europe, Asia/Pacific, Latin America)
• By Segment (Facial injectables, Cosmetic implants, Home-use devices, Physician-dispensed cosmeceuticals, Energy-based skin tightening devices, Skin rejuvenation devices, Body Contouring, Facial Reconstruction/Rejuvenation, Cosmetic Implants, Breast Lift, Liposuction, Abdominoplasty, Male Aesthetics)
• By Sub-Market (Injectable procedures, Facelift, Laser resurfacing/Photorejuvenation, Eyelid lift, Dermabrasion, chemical peel, Rhinoplasty, Forehead lift, Lip augmentation, Breast implants, Facial implants, Buttock, calf, pectoral implants, Skincare cosmeceuticals, Skin lightening cosmeceuticals, Eyelash cosmeceuticals, Scar removal products
• By Product Segment (Facial injectables, Botox, Dermafillers, Neuromodulators, Hyaluronic Acid, Collagen)
• By Company (e.g Allergen, Mentor, Galderma, Valeant, Merz, Syneron, Zetiq, Ulthera, Cynosure, Solta/Valeant, Alma/Fosun Pharma)
• By Market Leaders and Market Share in Cosmetic Neurotoxins, Derma Fillers, Home Use Devices, Body Shaping and Skin Tightening Devices
Currently, invasive aesthetic procedures generated revenues of $27,843.5 million in 2015. New Report indicate that by 2021, invasive aesthetic procedures will grow at a CAGR of 4.3%, to reach $27,843.5 million. Non-invasive procedures generated approximately $16,738 million in 2015 and will grow at a CAGR of 4.5% over the coming five years. They are expected to generate revenues of $16,738.0 million in 2021. Cosmetic surgery products generated $7,824.0 million in 2015 and have the potential to reach $13,934.0 million in 2021.
The global market for the medical aesthetics industry is presented by the following categories:
• By Geography (North America, Europe, Asia/Pacific, Latin America)
• By Segment (Facial injectables, Cosmetic implants, Home-use devices, Physician-dispensed cosmeceuticals, Energy-based skin tightening devices, Skin rejuvenation devices, Body Contouring, Facial Reconstruction/Rejuvenation, Cosmetic Implants, Breast Lift, Liposuction, Abdominoplasty, Male Aesthetics)
• By Sub-Market (Injectable procedures, Facelift, Laser resurfacing/Photorejuvenation, Eyelid lift, Dermabrasion, chemical peel, Rhinoplasty, Forehead lift, Lip augmentation, Breast implants, Facial implants, Buttock, calf, pectoral implants, Skincare cosmeceuticals, Skin lightening cosmeceuticals, Eyelash cosmeceuticals, Scar removal products
• By Product Segment (Facial injectables, Botox, Dermafillers, Neuromodulators, Hyaluronic Acid, Collagen)
• By Company (e.g Allergen, Mentor, Galderma, Valeant, Merz, Syneron, Zetiq, Ulthera, Cynosure, Solta/Valeant, Alma/Fosun Pharma)
• By Market Leaders and Market Share in Cosmetic Neurotoxins, Derma Fillers, Home Use Devices, Body Shaping and Skin Tightening Devices
